You've likely heard a million different warnings about the changes taking place in America's financial system right now... How the White House plans to take the dollar fully digital???

Jane H. Hollingsworth net worth and biography

Jane Hollingsworth Biography and Net Worth

Director of Diffusion Pharmaceuticals

Ms. Hollingsworth has served as a director since September 2020. She currently serves as Managing Partner of Militia Hill Ventures, an investment firm focused on building, growing and investing in high-quality life sciences companies, a role she has held since Militia Hill’s founding in 2013.

Prior to founding Militia Hill, Ms. Hollingsworth served as Executive Chair of Immunonome Inc., a cancer immunotherapy company, and co-founder and Chief Executive Officer of NuPathe, Inc., a publicly-traded biopharmaceutical company focused on diseases of the central nervous system, prior to the acquisition of NuPathe by Teva Pharmaceuticals in 2014. She also currently serves on the board of various industry and community organizations, including DS Biopharma, the University City Science Center, the Kimmel Center for the Performing Arts and Breatcancer.Org. Ms. Hollingsworth received her B.A. from Gettysburg College and her J.D. from Villanova University. Ms. Hollingsworth is a member of the Audit Committee and the Compensation Committee.

What is Jane H. Hollingsworth's net worth?: The estimated net worth of Jane H. Hollingsworth is at least $0.00 as of May 13th, 2021. Ms. Hollingsworth owns 21,857 shares of Diffusion Pharmaceuticals stock worth more than $0 as of April 25th. This net worth approximation does not reflect any other investments that Ms. Hollingsworth may own. Learn More about Jane H. Hollingsworth's net worth.
How do I contact Jane H. Hollingsworth?: The corporate mailing address for Ms. Hollingsworth and other Diffusion Pharmaceuticals executives is 1317 CARLTON AVENUE SUITE 200, CHARLOTTESVILLE VA, 22902. Diffusion Pharmaceuticals can also be reached via phone at (434) 220-0718 and via email at [email protected]. Learn More on Jane H. Hollingsworth's contact information.
Has Jane H. Hollingsworth been buying or selling shares of Diffusion Pharmaceuticals?: Jane H. Hollingsworth has not been actively trading shares of Diffusion Pharmaceuticals within the last three months. Most recently, on Thursday, May 13th, Jane H. Hollingsworth bought 21,857 shares of Diffusion Pharmaceuticals stock. The stock was acquired at an average cost of $0.9150 per share, with a total value of $19,999.1550. Following the completion of the transaction, the director now directly owns 21,857 shares of the company's stock, valued at $19,999.1550. Learn More on Jane H. Hollingsworth's trading history.

Jane H. Hollingsworth Insider Trading History at Diffusion Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/13/2021	Buy	21,857	$0.92	$19,999.16	21,857

Jane H. Hollingsworth Buying and Selling Activity at Diffusion Pharmaceuticals

Diffusion Pharmaceuticals Company Overview

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company was founded in 2001 and is based in Charlottesville, Virginia.

Today's Range

Now: N/A

50 Day Range

MA: $4.64

$4.38

$6.60

2 Week Range

Now: N/A

Volume

351,000 shs

Average Volume

10,937 shs

Market Capitalization

$8.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.78

Fed launches fourth dollar overhaul

From Stansberry Research | Ad